Nyxthracis (previously Obiltoxaximab SFL) 欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

nyxthracis (previously obiltoxaximab sfl)

sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imunitný séra a imunoglobulíny, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.

Regkirona 欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

regkirona

celltrion healthcare hungary kft. - regdanvimab - covid-19 virus infection - imunitný séra a imunoglobulíny, - regdanvimab is indicated for the treatment of adults with coronavirus disease 2019 (covid-19) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.

Hetlioz 欧盟 - 斯洛伐克文 - EMA (European Medicines Agency)

hetlioz

vanda pharmaceuticals netherlands b.v. - tasimelteon - poruchy spánku, cirkadiánny rytmus - psycholeptika - hetlioz je indikovaný na liečbu 24-hodinovej poruchy spánku (non-24) u úplne slepých dospelých.